La pharmacogénétique dans l'exercice médical quotidienBECQUEMONT, Laurent.MT. Médecine thérapeutique. 2005, Vol 11, Num 6, pp 437-445, issn 1264-6520, 9 p.Article

La pharmacogénétique en quelques définitions = Pharmacogenetics: an introductionLANCIA, P; DE BEAUMAIS, T. Adam; ELIE, V et al.Correspondances en onco-hématologie. 2014, Vol 9, Num 6, pp 194-197, issn 1954-4820, 4 p.Article

Intérêt des outils d'investigation des enzymes métaboliques en pratique clinique : PHARMACOGÉNÉTIQUE DE LA DOULEUR = Investigation tools for metabolic enzymes in clinical practice : PHARMACOGENETICS OF PAINSAMER, C. F; ROLLASON, V; ING LORENZINI, K et al.Douleur et analgésie. 2013, Vol 26, Num 4, pp 241-247, issn 1011-288X, 7 p.Article

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in manKUPFER, A; PREISIG, R.European journal of clinical pharmacology. 1984, Vol 26, Num 6, pp 753-759, issn 0031-6970Article

Intégration de la pharmacogénétique dans la pratique médicale = Integration of pharmacogenetics in the medical practiceDIDEBERG, V; BOURS, V.RMLG. Revue médicale de Liège. 2005, Vol 60, Num 12, pp 918-922, issn 0370-629X, 5 p.Article

Pharmacogenetics and geographical ancestry: implications for drug development and global healthDAAR, Abdallah S; SINGER, Peter A.Nature reviews. Genetics (Print). 2005, Vol 6, Num 3, pp 241-246, issn 1471-0056, 6 p.Article

ADVANCES IN PHARMACOGENETICSVESELL ES.1973; PROGR. MED. GENET.; U.S.A.; DA. 1973; VOL. 9; PP. 291-367; BIBL. 12P.1/2Serial Issue

Influence of genetic polymorphism on the metabolism and disposition of encainide in manTWANG, T; RODEN, D. M; WOLFENDEN, H. T et al.The Journal of pharmacology and experimental therapeutics. 1984, Vol 228, Num 3, pp 605-611, issn 0022-3565Article

A Population Pharmacokinetic-Pharmacogenetic Analysis of AtazanavirKILE, Deidre A; MAWHINNEY, Samantha; AQUILANTE, Christina L et al.AIDS research and human retroviruses. 2012, Vol 28, Num 10, pp 1227-1234, issn 0889-2229, 8 p.Article

Pharmacogenetic profiling might meet the challengeJOLOBE, Oscar M. P.Journal of internal medicine. 2011, Vol 270, Num 5, pp 494-495, issn 0954-6820, 2 p.Article

Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation: characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiencyDAYER, P; KRONBACH, T; EICHELBAUM, M et al.Biochemical pharmacology. 1987, Vol 36, Num 23, pp 4145-4152, issn 0006-2952Article

Pharmacogenetics of opioidsSOMOGYI, Andrew A; BARRATT, Daniel T; COLLER, Janet K et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 3, pp 429-444, issn 0009-9236, 16 p.Article

Pharmacogenetics: potential for individualized drug therapy through geneticsJOHNSON, Julie A.Trends in genetics (Regular ed.). 2003, Vol 19, Num 11, pp 660-666, issn 0168-9525, 7 p.Article

PHARMACOGENETICS OF HUMAN THIOPURINE METHYLTRANSFERASE: KIDNEY-ERYTHROCYTE CORRELATION AND IMMUNOTITRATION STUDIESWOODSON LC; DUNNETTE JH; WEINSHILBOUM RM et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 222; NO 1; PP. 174-181; BIBL. 22 REF.Article

PHARMACOGENETICSVESELL ES.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 4; PP. 445-450; BIBL. 62 REF.Article

Les actualités sur la pharmacogénétiqueBECQUEMONT, Laurent.La Lettre du pharmacologue (Boulogne). 2013, Vol 27, Num 3, issn 0984-452X, 24 p.Serial Issue

Pharmacogenetics : From Bench to ByteSWEN, J. J; WILTING, I; KOOPMANS, R et al.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 5, pp 781-787, issn 0009-9236, 7 p.Article

Pharmacogenetics : focus on pharmacodynamicsLINDPAINTNER, Klaus; FOOT, Elizabeth; CAULFIELD, Mark et al.International journal of pharmaceutical medicine. 2001, Vol 15, Num 2, pp 74-82, issn 1364-9027Article

Challenges in pharmacogeneticsCASCORBI, Ingolf; BRUHN, Oliver; WERK, Anneke N et al.European journal of clinical pharmacology. 2013, Vol 69, issn 0031-6970, S17-S23, SUP1Article

Pharmacosynthetics: Reimagining the pharmacogenetic approachFARRELL, Martilias S; ROTH, Bryan L.Brain research. 2013, Vol 1511, pp 6-20, issn 0006-8993, 15 p.Article

PHARMACOGENETICS: PART IGIBALDI, Milo.The Annals of pharmacotherapy. 2007, Vol 41, Num 12, pp 2042-2047, issn 1060-0280, 6 p.Article

ADRIS: The Adverse Drug Reactions Information schemeHUG, Hubert; BAGATTO, Dario; DANNECKER, Robert et al.Pharmacogenetics (London). 2003, Vol 13, Num 12, pp 767-772, issn 0960-314X, 6 p.Article

Validating and Using Pharmacogenomics: Joint IFCC-Roche Diagnostics Conference, Kyoto, Japan, 16-19 April 2000Clinical chemistry and laboratory medicine. 2000, Vol 38, Num 9, issn 1434-6621, 143 p.Conference Proceedings

GENETIC FACTORS IN THE RESPONSE TO ORAL ANTICOAGULANT DRUGS = FACTEURS GENETIQUES DE LA REPONSE AUX MEDICAMENTS ORAUX ANTICOAGULANTSO'REILLY RA.1973; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1973; NO 250; PP. 428-442; BIBL. 2P.; (C.R. IVE CONGR. INT. GENET. HUM.; PARIS; 1971)Conference Paper

PHARMACOGENETICS OF DRUGS USED IN ANAESTHESIA = PHARMACOGENETIQUE DES PRODUITS UTILISES EN ANESTHESIEKALOW W.1973; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1973; NO 250; PP. 415-427; BIBL. 3P.; (C.R. IVE CONGR. INT. GENET. HUM.; PARIS; 1971)Conference Paper